Literature DB >> 33881787

The effects of cell surface CD47 downregulation on ischaemia-reperfusion injury during pig liver transplantation.

Zhi Wang1, Hao Guo1, Rui Xu1, Chun-Ni Zhao2, Yun Xia3,4.   

Abstract

This study aimed to investigate the effect of cell surface CD47 downregulation on ischaemia-reperfusion injury (IRI) during pig liver transplantation. Blood samples were collected from healthy miniature Bama pigs randomly and equally divided into CD47 antagonism (group A), without CD47 antagonism (group B) and a sham group (group C). Blood samples were collected from groups A and B at 0, 8 and 48 hours after establishment of the new liver through an indwelling tube in the right internal jugular vein. Blood samples were collected at the same time points after liver dissociation from group C. The expression of interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α) was detected by enzyme-linked immunosorbent assay (ELISA); CD47 expression was detected by Western blot; and liver function indices, including alanine aminotransferase (ALT) and aspartic transaminase (AST), were directly read by an automatic biochemical analyzer. The concentrations of both receptors in group A were significantly lower than groups B and C, at 8 and 48 hours after establishment of blood flow. At 8 and 48 hours in the new liver stage, the values of CD47 levels, ALT and AST in group A were significantly reduced compared to groups B and C (P < 0.05). The levels of CD47 in the three groups were consistent with the trends of the aforementioned observation indicators. The liver functions of the recipients were significantly improved by reducing the release of the inflammatory mediators. This study provides new ideas and intervention approaches for the treatment of IRI in liver transplantation.
© 2021 Company of the International Journal of Experimental Pathology (CIJEP).

Entities:  

Keywords:  CD47; inflammatory stress; ischaemia-reperfusion injury; orthotopic liver transplantation

Mesh:

Substances:

Year:  2021        PMID: 33881787      PMCID: PMC8139379          DOI: 10.1111/iep.12391

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   2.793


  28 in total

1.  Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP.

Authors:  Mingyi Yao; David D Roberts; Jeff S Isenberg
Journal:  Pharmacol Res       Date:  2010-10-29       Impact factor: 7.658

2.  [Protective effect of ischemic preconditioning on hepatic state in its ischemic-reperfusion injury].

Authors:  O M Oleshchuk
Journal:  Klin Khir       Date:  2013-04

Review 3.  Macrophages, dendritic cells, and kidney ischemia-reperfusion injury.

Authors:  Li Li; Mark D Okusa
Journal:  Semin Nephrol       Date:  2010-05       Impact factor: 5.299

Review 4.  Hepatic ischemia-reperfusion injury.

Authors:  F Serracino-Inglott; N A Habib; R T Mathie
Journal:  Am J Surg       Date:  2001-02       Impact factor: 2.565

5.  Increasing survival of ischemic tissue by targeting CD47.

Authors:  Jeff S Isenberg; Martin J Romeo; Mones Abu-Asab; Maria Tsokos; Anna Oldenborg; Loretta Pappan; David A Wink; William A Frazier; David D Roberts
Journal:  Circ Res       Date:  2007-02-09       Impact factor: 17.367

6.  Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling.

Authors:  Jeff S Isenberg; Martin J Romeo; Christine Yu; Christine K Yu; Khauh Nghiem; Jude Monsale; Margaret E Rick; David A Wink; William A Frazier; David D Roberts
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

7.  Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling.

Authors:  Jeff S Isenberg; Justin B Maxhimer; Perlita Powers; Maria Tsokos; William A Frazier; David D Roberts
Journal:  Surgery       Date:  2008-09-02       Impact factor: 3.982

8.  Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice.

Authors:  Thorsten Eismann; Nadine Huber; Thomas Shin; Satoshi Kuboki; Elizabeth Galloway; Michael Wyder; Michael J Edwards; Kenneth D Greis; Howard G Shertzer; Aron B Fisher; Alex B Lentsch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-25       Impact factor: 4.052

Review 9.  The CD47-SIRPα signalling system: its physiological roles and therapeutic application.

Authors:  Yoji Murata; Takenori Kotani; Hiroshi Ohnishi; Takashi Matozaki
Journal:  J Biochem       Date:  2014-03-12       Impact factor: 3.387

10.  CD47 overexpression is associated with decreased neutrophil apoptosis/phagocytosis and poor prognosis in non-small-cell lung cancer patients.

Authors:  Lourdes Barrera; Edgar Montes-Servín; Juan-Manuel Hernandez-Martinez; María de Los Ángeles García-Vicente; Elizabeth Montes-Servín; Marytere Herrera-Martínez; José C Crispín; José Rafael Borbolla-Escoboza; Oscar Arrieta
Journal:  Br J Cancer       Date:  2017-06-20       Impact factor: 7.640

View more
  1 in total

1.  The effects of cell surface CD47 downregulation on ischaemia-reperfusion injury during pig liver transplantation.

Authors:  Zhi Wang; Hao Guo; Rui Xu; Chun-Ni Zhao; Yun Xia
Journal:  Int J Exp Pathol       Date:  2021-04-21       Impact factor: 2.793

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.